A very recent two-hit approach combined metabolic syndrome, as a consequence of obese ZSF1 with double–leptin receptor defect, and pulmonary endothelial impairment by the VEGF receptor antagonist, SU5416. This evidence concerns the gene LEPR and metabolic syndrome.